Omega Healthcare price target lowered to $29 from $32 at Baird

Baird analyst David Rodgers lowered the firm’s price target on Omega Healthcare to $29 from $32 and keeps a Neutral rating on the shares. The analyst said a combination of higher expenses, limited labor availability and challenged occupancy levels are resulting in ongoing rent deferrals, master lease restructuring and interest payment deferrals for Skilled Nursing tenants overall.